跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
郭 雲鼎
副教授
,
小兒學科
主治醫師
,
衛生福利部雙和醫院
https://orcid.org/0000-0002-4579-9421
電子郵件
pedkuoyt
tmu.edu
tw
h-index
491
引文
14
h-指數
按照存儲在普爾(Pure)的出版物數量及斯高帕斯(Scopus)引文計算。
2005
2024
每年研究成果
概覽
指紋
網路
專案
(9)
研究成果
(38)
資料集
(4)
類似的個人檔案
(6)
指紋
查看啟用 Yung-Ting Kuo 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Medicine and Dentistry
COVID-19
100%
Infection
81%
Epileptic Seizure
74%
Omicron Coronavirus Variant
66%
Severe Acute Respiratory Syndrome Coronavirus 2
66%
Drug Resistant Epilepsy
66%
Intractable Epilepsy
66%
Vagus Nerve Stimulation
66%
Disease
52%
Pediatrics
50%
Neurologic Finding
41%
Lung Dysplasia
38%
Corticotropin
33%
Ibuprofen
33%
Brain Edema
33%
Ring Chromosome
33%
Chromosome 18
33%
Array Comparative Genomic Hybridization
33%
Disomy
33%
Infantile Spasm
33%
Mycoplasma Pneumonia
33%
Brain Blood Flow
33%
Cerebrovascular Disease
33%
Blood Flow Velocity
33%
Systematic Review
33%
Meta-Analysis
33%
Fulminant
33%
Asphyxia
33%
Magnetic Resonance Imaging
33%
Hematoma
33%
Parental Stress
33%
Therapy Effect
33%
Neonatal Infant
33%
Mitochondrion
33%
Indometacin
33%
Sirtuin1
33%
Ganglioneuroblastoma
33%
Extremely Low Birth Weight
33%
Kidney Function
33%
Mosaicism
33%
Acute Respiratory Tract Disease
33%
Diabetes Mellitus
33%
Neuroblastoma Cell
33%
Budesonide
33%
Drug Resistance
33%
Rhinovirus
33%
Respiratory Syncytial Virus
33%
Vascular Disease
33%
Coronavirinae
33%
Frameshift Mutation
33%
Biochemistry, Genetics and Molecular Biology
Oxidoreductase
73%
Mouse
66%
Beta Oxidation
66%
Stem Cell
66%
Dehydrogenase
59%
Ubiquinone
54%
Electron Transport
42%
Flavoprotein
42%
Gene Mutation
41%
Energy Metabolism
40%
Bioenergy
40%
Electron Transport Chain
38%
Enzyme Activity
37%
Coenzyme Q10
35%
Palmitic Acid
35%
Infrared Radiation
33%
Adipose Triglyceride Lipase
33%
Mitochondrion
33%
Lipolysis
33%
Cell Energy
33%
IRF6
33%
Sirtuin1
33%
C2C12
33%
Skeletal Muscle
33%
Hypoxia Inducible Factor 1
33%
Functional Status
33%
Standing
33%
Infancy
33%
Forced Vital Capacity
33%
Lipid
33%
Oxidative Phosphorylation
33%
Mutagenesis
33%
Frameshift Mutation
33%
Pyrin Domain
33%
Glucosidase
33%
Adenosine Monophosphate
33%
NOD-like Receptor
33%
Phosphotransferase
33%
Kinase
33%
Ring Chromosome
33%
Inflammasome
33%
Sirtuin 1
33%
Lipid Storage
33%
Fluorescence in Situ Hybridization
33%
Chromosome 18
33%
Disomy
33%
Array Comparative Genomic Hybridization
33%
Drug Resistance
33%
JARID1B
33%
Long Non-Coding RNA
33%
Pharmacology, Toxicology and Pharmaceutical Science
Alpha-Lipoic Acid
66%
Infantile Spasm
66%
Corticotropin
66%
Disease
58%
Lung Dysplasia
38%
Palmitic Acid
37%
Intractable Epilepsy
36%
6 N Carboxymethyllysine
33%
Budesonide
33%
Extremely Low Birth Weight
33%
Therapeutic Effect
33%
Neuroblastoma
33%
Fucoxanthin
33%
Long Untranslated RNA
33%
Pyrroloquinolinequinone
33%
Drug Resistant Epilepsy
33%
Dosage Forms
33%
Acute Respiratory Tract Disease
33%
Virus Pneumonia
33%
Ibuprofen
33%
Muscle Atrophy
33%
Coronavirinae
33%
Indometacin
33%
Isotopes of Potassium
33%
Drug Resistance
33%
Vascular Disease
33%
Vaccination Policy
33%
Hormone Cancer Therapy
33%
Pancreatic Lipase
33%
Neurologic Disease
33%
Cerebrovascular Disease
33%
Muscle Spasm
30%
Prematurity
29%
Infection
25%
Hypsarrhythmia
22%
Gastrointestinal Symptom
22%
Reactive Oxygen Metabolite
20%
Rhinovirus
18%
Infectious Agent
18%
Corticosteroid
17%
Lipoic Acid
16%
Mouse
16%
Adverse Event
16%
Anticonvulsive Agent
16%
Bovine Serum Albumin
16%
Side Effect
14%
Randomized Controlled Trial
14%
Hypoxia Inducible Factor 1
12%
Fatty Liver
12%
Hydroxymethylglutaryl Coenzyme A Reductase Kinase
12%